Koning HK

Koning HK, a subsidiary of Koning Global
Koning HK, a subsidiary of Koning Global

Koning Health is a finalist for the 2023 Sharecare Award: Innovative Breast Imaging Technology Watch on Youtube Watch the experience of Koning Vera Breast CT Watch on Youtube Koning Vera Breast CT now offered at Brookwood Baptist Hospital Learn More Introducing Koning Vera Breast CT! Koning is launching Vera by Koning, the latest version of our breast CT device. Vera introduces a reduced 7-second scanning time per breast. It is a multifunctional device capable of 3D guided biopsy, and does so at radiation dose levels comparable to mammography. Learn More A Better Way of Breast Imaging Breast cancer is treatable if detected early enough. Standard mammography misses 30% of cancers, preventing women from receiving the intervention they need. Koning's NO-COMPRESSION, TRUE 3D Breast CT solves this problem. Learn More The Difference is Clear Learn more about how KBCT is superior to mammography. View Our Locations Revolutionary breast imaging available worldwide Koning Breast Computed Tomography is Available Worldwide

The breast imaging industry is getting an upgrade with
Koning's advanced computed tomography technology

We believe our Koning Vera Breast CT will dramatically improve the way clinicians visualize & evaluate breast tissue. Our technology is expected to optimize early disease detection, diagnosis, intervention & treatment. Our hope is to be able to improve survival rates and outcomes for millions of patients. We believe that the power, versatility & lower cost of Koning Vera Breast CT will serve as a viable substitute for many traditional imaging applications.

About Us

Statistics

43k

Breast cancer deaths
expected in 2023

99%

5-year survival rate
with stage 0 and 1
detection

22%

5-year survival rate
with stage 4
detection

3/10

Current breast
imaging devices fail
to demonstrate as
many as 30% of
breast cancers

Breast cancer is more treatable
with early detection

Five-year survival for stage 0-1 is 99%. However, current tools available – specifically
mammography – are inadequate, missing 35% of cancers. That increases to 70% in
women with dense breasts.

Our technology provides tools that allow a physician to detect cancers as early as
stage 0 and stage 1, finding lesions as small as 2mm and calcifications as small as
200 microns.

 What we do

Koning has been developing cone-beam CT technology for over two decades. As the winner of multiple awards including the 2016 Frost and Sullivan New Innovation Award in Breast Imaging, and as holder of over 120 patents globally, Koning has developed technology to bring a better breast imaging solution to women around the world.

Diagnostic Work Ups

Post-op Monitoring

3D Guided Biopsy

Neoadjuvant Monitoring

Small, Dense Breasts

Post-op Monitoring

3D Guided Biopsy

Neoadjuvant Monitoring

Each Output of a Scan is a 3D Image

Non-contrast

Contrast
Enhanced

Blood Vessels

Calcifications

Watch the Koning Breast Computed Tomography in action

Koning’s 3D KBCT produces high-contrast real 3D images of the breast with exceptional spatial resolution, no painful compression, in a rapid 7-second exposure, at radiation levels in the range of diagnostic mammograms.

Early detection improves intervention

Koning Breast Computed Tomography is Available Worldwide